Cargando…
A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma
BACKGROUND & AIMS: Intratumour heterogeneity (ITH) fosters the vulnerability of RNA expression-based biomarkers derived from a single biopsy to tumour sampling bias, and is regarded as an unaddressed confounding factor for patient precision stratification using molecular biomarkers. This study a...
Autores principales: | Luo, Shangyi, Jia, Ying, Zhang, Yajing, Zhang, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206488/ https://www.ncbi.nlm.nih.gov/pubmed/37234275 http://dx.doi.org/10.1016/j.jhepr.2023.100754 |
Ejemplares similares
-
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
por: Dunne, Philip D., et al.
Publicado: (2017) -
Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019) -
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2021) -
Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer
por: Lubbock, Alexander L. R., et al.
Publicado: (2017) -
Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma
por: Yang, Jie, et al.
Publicado: (2021)